Biblio Discovery — Demo Discovery Service

4 results for "Li-xia Wang"

Showing 1–4 · 2.96 seconds · RSS

  1. Journal Article Full text

    Association between the Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor Gamma 2 and Inflammatory Bowel Disease: A Meta-Analysis

    Zhi-Feng Zhang; Ning Yang; Gang Zhao et al.

    PLoS ONE, Vol. 7 No. 1 · 2012 · English · PLOS Scopus

    Background: Peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear receptor, has been implicated playing a role in the development of inflammatory bowel disease (IBD). However, previous studies evaluating the association between the PPARγ2 Pro12Ala polymorphism and IBD are…

  2. Journal Article Full text

    Seasonal Variations in Notification of Active Tuberculosis Cases in China, 2005–2012

    Xin-Xu Li; Li-Xia Wang; Hui Zhang et al.

    PLoS ONE, Vol. 8 No. 7 · 2013 · English · PLOS Scopus

    Background: Although seasonal variation in tuberculosis (TB) incidence has been described in many countries, it remains unknown in China. Methods: A time series decomposition analysis (X-12-ARIMA) was performed to examine the seasonal variation in active TB cases nationwide from 2005 through 2012…

  3. Journal Article Full text

    Co-endemicity of Pulmonary Tuberculosis and Intestinal Helminth Infection in the People’s Republic of China

    Xin-Xu Li; Zhou-Peng Ren; Li-Xia Wang et al.

    PLOS Neglected Tropical Diseases, Vol. 10 No. 4 · 2016 · English · PLOS Scopus

    Both pulmonary tuberculosis (PTB) and intestinal helminth infection (IHI) affect millions of individuals every year in China. However, the national-scale estimation of prevalence predictors and prevalence maps for these diseases, as well as co-endemic relative risk (RR) maps of both diseases’…

  4. Journal Article Full text

    Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment

    Guang Xue He; Yan Guang Xie; Li Xia Wang et al.

    PLoS ONE, Vol. 5 No. 5 · 2010 · English · PLOS Scopus

    Background: In 2004, an anti-tuberculosis (TB) drug resistance survey in Heilongjiang province, China, enrolled 1574 (79%) new and 421 (21%) retreatment patients. Multi-drug resistant (MDR) TB was detected in 7.2% of new and 30.4% of retreatment patients. All received treatment with standardized…